Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

aflibercept monotherapy; polypoidal choroidal vasculopathy; neovascular age-related macular degeneration; good baseline visual acuity; ForeseeHome AMD Monitoring System®; AREDS2-HOME study; age-related macular degeneration; exudation; optical coherence tomography angiography; anti-vascular endothelial growth factor; brolucizumab; epithelial tear; optical coherence tomography; Sorsby’s fundus dystrophy; Sorsby; hereditary retinal dystrophy; choroidal neovascularisation; macular neovascularization; anti-VEGF treatment; long-term FU; treatment outcome; emerging treatment; neovascular age-related macular degeneration (nAMD); Vascular Endothelial Growth Factor (VEGF); cataract surgery; clinical trials; real-world evidence; AMD; oct-angiography; fellow eye; choriocapillaris; quiescent macular neovascularization; ranibizumab; aflibercept; anti-VEGF; visual acuity; reading acuity; disease activity; treatment change; treat and extend; switch therapy; retina; choroidal neovascularization; angiogenesis; meteorin; therapeutic innovation; prevention; nutrients; lifestyle; treatment-naive; anti–vascular endothelial growth factor; cardiovascular risk factors; arterial hypertension; macula-off rhegmatogenous detachment; superficial perifoveal capillary plexus; retinal deep perifoveal capillary plexus; identification; risk; Delphi; STARS®; food supplement; bevacizumab; meta-analysis; meta-regression; n/a; age-related macular degeneration (AMD); comparative therapies; effectiveness; intravitreal anti-vascular endothelial growth factor; treat-and-extend; pro re nata regimen